This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Joan Stephenson, PhD

JAMA. 2001;286:159.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Counterfeit medications and drugs containing the wrong dose or lacking the active ingredient threaten the health of people in some developing countries, according to two reports in the June 16 issue of Lancet.

Nearly half of 581 samples of 27 different drugs from 38 pharmacies in Lagos and Abuja in Nigeria contained the wrong dose of drug—too little, too much, or none of the active ingredient—according to a team of researchers from the United Kingdom, Thailand, and Nigeria. In the second study, researchers from Mahidol University in Bangkok and other institutions found that 38% of 104 samples of an antimalarial medication bought from shops in Cambodia, Laos, Myanmar, Thailand, and Vietnam contained no artesunate, the key ingredient.

In a commentary in the same issue, Alain Li Wan Po, PhD, of the Center for Evidence-Based Pharmacotherapy at Aston University, Birmingham, England, called for measures to raise drug . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?